As of today (2024-05-12), Encision's share price is $0.57.
Encision's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.00. Hence, Encision's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Encision's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, Encision's highest Price-to-Free-Cash-Flow Ratio was 496.67. The lowest was 8.25. And the median was 45.56.
ECIA's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.64 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -54.80% per year.
During the past 13 years, Encision's highest 3-Year average Free Cash Flow per Share Growth Rate was 56.80% per year. The lowest was -58.70% per year. And the median was -8.80% per year.
Encision Price-to-Free-Cash-Flow Historical Data
The historical data trend for Encision's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Encision's Price-to-Free-Cash-Flow
For the Medical Instruments & Supplies subindustry, Encision's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encision's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Encision's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Encision's Price-to-Free-Cash-Flow falls into.
Encision Price-to-Free-Cash-Flow Calculation
Encision's Price-to-Free-Cash-Flow ratio for today is calculated as
Encision's Share Price of today is $0.57. Encision's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Encision Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Encision's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ECIA has been successfully added to your 